story of the week
Intracranial and Extracranial Efficacy of Lorlatinib in ALK-Positive Previously Treated NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intracranial and Extracranial Efficacy of Lorlatinib in Patients With ALK-Positive Non-Small-Cell Lung in Cancer Previously Treated With Second-Generation ALK TKIs
Ann. Oncol 2021 Feb 24;[EPub Ahead of Print], E Felip, AT Shaw, A Bearz, DR Camidge, BJ Solomon, JR Bauman, TM Bauer, S Peters, F Toffalorio, A Abbattista, H Thurm, G Peltz, R Wiltshire, B BesseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.